SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022617
Filing Date
2022-08-15
Accepted
2022-08-15 09:01:07
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 852415
2 ex31-1.htm EX-31.1 11051
3 ex31-2.htm EX-31.2 10330
4 ex32-1.htm EX-32.1 4740
  Complete submission text file 0001493152-22-022617.txt   4823209

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brtx-20220630.xsd EX-101.SCH 34649
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brtx-20220630_cal.xml EX-101.CAL 44896
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brtx-20220630_def.xml EX-101.DEF 163815
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brtx-20220630_lab.xml EX-101.LAB 322861
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brtx-20220630_pre.xml EX-101.PRE 260522
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 809542
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 221162661
SIC: 8090 Services-Misc Health & Allied Services, NEC